Rich Shea | CEO, Basking Biosciences – RNA Aptamers for Acute Thrombosis Treatment

from Executive Insights for Life Sciences Innovators · host GeneCoda® Executive Search

In this episode of Executive Insights for Life Sciences Innovators, we sit down with Rich Shea, CEO of Basking Biosciences, to discuss the company’s pioneering work with RNA aptamer technology for the treatment of acute thrombosis. Rich shares insights on Basking’s scientific journey, the challenges of advancing a novel therapeutic approach, and the opportunities ahead in cardiovascular care.Learn more at genecoda.com.Originally recorded and streamed on YouTube Live on February 24, 2025.

Episode metadata supplied by the publisher feed · Published Sep 8, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Rich Shea | CEO, Basking Biosciences – RNA Aptamers for Acute Thrombosis Treatment

0:00 30:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Executive Insights for Life Sciences Innovators?

This episode is 30 minutes long.

When was this Executive Insights for Life Sciences Innovators episode published?

This episode was published on September 8, 2025.

Can I download this Executive Insights for Life Sciences Innovators episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!